Exciting times ahead for biomedical sector in Malaysia


PHILADELPHIA: Exciting times are ahead for Malaysia when one of the top Asian biopharmaceutical giants Biocon Ltd begins operations in the country next year.

Malaysia Biotechnology Corp (Biotech Corp) biomedical section senior vice-president Jay Padasian said it had taken about two years to convince the company to set up its integrated insulin plant in Malaysia.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

News , bureaus , biomedical , malaysia ,

   

Next In Business News

Eupe fourth-quarter profit rises 29%
Meta projects higher spending, weaker revenue
Buyout proposal for Anglo American could reshape copper market
Axiata, Sinar Mas move closer to US$3.5bil merger
A test bed for airline subscription model
Pantech seeks to list steel pipe units
AI memory boom propels SK Hynix’s numbers
Battery stocks’ rally in India likely to extend
Congo accuses Apple of using ‘blood minerals’ from war-torn east
Higher earnings for Pavilion-REIT

Others Also Read